000566 Hainan Haiyao
- 3.58
- -0.01-0.28%
Hainan Haiyao News
Hainan Haiyao (SZSE:000566) Sheds CN¥363m, Company Earnings and Investor Returns Have Been Trending Downwards for Past Five Years
We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly. For example the Hainan Haiyao Co., Ltd. (SZSE:000566) share price dropped 61% ove
Individual Investors in Hainan Haiyao Co., Ltd. (SZSE:000566) Are Its Biggest Bettors, and Their Bets Paid off as Stock Gained 11% Last Week
Key Insights The considerable ownership by individual investors in Hainan Haiyao indicates that they collectively have a greater say in management and business strategy The top 19 shareholders own 4
Hainan Haiyao's Antibiotic Passes Generic Evaluation
Hainan Haiyao (SHE:000566) said its cefuroxime sodium for injection, an antibiotic, has passed China's national generic drug quality and efficacy consistency evaluation. The antibiotic is indicated fo
Hainan Haiyao Co., Ltd.'s (SZSE:000566) Popularity With Investors Is Under Threat From Overpricing
With a median price-to-sales (or "P/S") ratio of close to 3.5x in the Pharmaceuticals industry in China, you could be forgiven for feeling indifferent about Hainan Haiyao Co., Ltd.'s (SZSE:000566) P/
Further Weakness as Hainan Haiyao (SZSE:000566) Drops 7.7% This Week, Taking Three-year Losses to 51%
If you are building a properly diversified stock portfolio, the chances are some of your picks will perform badly. Long term Hainan Haiyao Co., Ltd. (SZSE:000566) shareholders know that all too well,
Hainan Haiyao's Unit Gets Nod to Become Marketing License Holder of Shuangshen Huoxue Tongluo Granules
China's National Medical Products Administration approved Hainan Haiyao's (SHE:000566) unit, Haikou Pharmaceutical Factory, to become the drug marketing license holder of the Shuangshen Huoxue Tongluo
Hainan Haiyao Co., Ltd.'s (SZSE:000566) Stock Price Dropped 7.8% Last Week; Individual Investors Would Not Be Happy
Key Insights Significant control over Hainan Haiyao by individual investors implies that the general public has more power to influence management and governance-related decisions The top 21 shareho
Hainan Haiyao (SZSE:000566) Is Making Moderate Use Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' It's only n
Hainan Haiyao Unit Receives 1.2 Million Yuan Government Subsidy
Hainan Haiyao (SHE:000566) has received 1.2 million yuan in government subsidy from the local government of Haikou City in China's Hainan province. The subsidy was issued in relation to the company's
Hainan Haiyao Co., Ltd.'s (SZSE:000566) Business Is Yet to Catch Up With Its Share Price
It's not a stretch to say that Hainan Haiyao Co., Ltd.'s (SZSE:000566) price-to-sales (or "P/S") ratio of 3.8x right now seems quite "middle-of-the-road" for companies in the Pharmaceuticals industry
Hainan Haiyao Co., Ltd.'s (SZSE:000566) Market Cap Surged CN¥506m Last Week, Individual Investors Who Have a Lot Riding on the Company Were Rewarded
Key Insights The considerable ownership by individual investors in Hainan Haiyao indicates that they collectively have a greater say in management and business strategy A total of 18 investors have
Why Hainan Haiyao's (SZSE:000566) Earnings Are Better Than They Seem
Hainan Haiyao Co., Ltd.'s (SZSE:000566) solid earnings announcement recently didn't do much to the stock price. Our analysis suggests that shareholders might be missing some positive underlying facto
Hainan Haiyao (SZSE:000566) Shareholders Are up 12% This Past Week, but Still in the Red Over the Last Three Years
Hainan Haiyao Co., Ltd. (SZSE:000566) shareholders should be happy to see the share price up 21% in the last quarter. But that doesn't change the fact that the returns over the last three years hav
Hainan Haiyao Unit's Minocycline Hydrochloride Capsules Passes Drug Regulator's Evaluation
04:55 AM EST, 03/08/2023 (MT Newswires) -- Haikou Pharmaceutical Factory, a unit of Hainan Haiyao (SHE:000566), received notification that minocycline hydrochloride capsules passed the consistency eva
Hainan Haiyao Unit Gets Regulatory Nod for Antibacterial Drug
02:33 AM EST, 01/31/2023 (MT Newswires) -- Haikou Pharmaceutical Factory, a subsidiary of Hainan Haiyao (SHE:000566), received approval from China's National Medical Products Administration for its ce
Hainan Haiyao Gets Regulatory Nod for Anti-Skin Disease Drug
05:12 AM EST, 01/09/2023 (MT Newswires) -- Hainan Haiyao (SHE:000566) unit Haikou Pharmaceutical Factory obtained regulatory approval for the registration of desloratadine oral solution drug. The drug
Hainan Haiyao (SZSE:000566) Adds CN¥363m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 61%
While it may not be enough for some shareholders, we think it is good to see the Hainan Haiyao Co., Ltd. (SZSE:000566) share price up 14% in a single quarter. But that can't change the reality that
Is Hainan Haiyao (SZSE:000566) A Risky Investment?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously said that 'Volatility is far from synonymous with risk.' So it might be obvious
Further Weakness as Hainan Haiyao (SZSE:000566) Drops 6.2% This Week, Taking Five-year Losses to 67%
Generally speaking long term investing is the way to go. But that doesn't mean long term investors can avoid big losses. For example, after five long years the Hainan Haiyao Co., Ltd. (SZSE:000566)
We Think Hainan Haiyao (SZSE:000566) Has A Fair Chunk Of Debt
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it might
Analysis
Price Target
No Data
